Author:
Atkinson Thomas M.,Li Yuelin,Coffey Charles W.,Sit Laura,Shaw Mary,Lavene Dawn,Bennett Antonia V.,Fruscione Mike,Rogak Lauren,Hay Jennifer,Gönen Mithat,Schrag Deborah,Basch Ethan
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference23 articles.
1. NCI: National Cancer Institute. (2001). Cancer therapy evaluation program. NCI guidelines—Expedited adverse event reporting requirements for NCI investigational agents. Bethesda: National Cancer Institute.
2. Basch, E., Iasonos, A., Barz, A., et al. (2007). Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. Journal of Clinical Oncology, 25, 5374–5380.
3. Basch, E. (2010). The missing voice of patients in drug-safety reporting. New England Journal of Medicine, 362, 865–869.
4. Basch, E., Jia, X., Heller, G., et al. (2009). Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes. Journal of the National Cancer Institute, 101, 1624–1632.
5. Belknap, S. M., Georgopoulos, C. H., West, D. P., et al. (2010). Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs. Clinical Pharmacology and Therapeutics, 88, 231–236.
Cited by
189 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献